Drug application
IBANDRONATE SODIUM (IBANDRONATE SODIUM)
Drugs@FDA ANDA 204329 · NANG KUANG PHARM CO
Key facts
| Drug name | IBANDRONATE SODIUM |
|---|---|
| Active ingredients | IBANDRONATE SODIUM |
| Application type | ANDA |
| Application number | 204329 |
| Company | NANG KUANG PHARM CO |
| Dosage forms | INJECTABLE, INTRAVENOUS |
| Strength | EQ 3MG BASE/3ML |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | Jun 16, 2021 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.